With a working model suggesting that DIO drives white matter endothelial CXCL5 expression through IL-17B/IL-17Rb signaling, we sought to establish the relevance of this signaling cascade to human cerebral small vessel disease and vascular cognitive impairment. This evidence concerns the gene IL17B and cerebral small vessel disease.